Last reviewed · How we verify
Anaphylaxis Adjunct
Approved treatments
- Hispril · GSK
- Pyribenzamin · Novartis
- Phenazoline · Novartis
- Thenylene
- Azatidine
- Tavist
- Clemastin · Technical University of Munich
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Anaphylaxis Adjunct patent landscape — cliff calendar, originator estates, attackable patents
- Anaphylaxis Adjunct treatment landscape brief
- Anaphylaxis Adjunct treatment updates RSS
Frequently asked questions about Anaphylaxis Adjunct
What drugs treat Anaphylaxis Adjunct?
Tracked treatments include Hispril, Pyribenzamin, Phenazoline, Thenylene, Azatidine, Tavist, Clemastin.
What is the treatment for Anaphylaxis Adjunct?
Standard treatment for Anaphylaxis Adjunct includes Hispril, Pyribenzamin, Phenazoline, Thenylene, Azatidine. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Anaphylaxis Adjunct patent cliff · Anaphylaxis Adjunct CI report
- Treatment: Hispril · GSK
- Treatment: Pyribenzamin · Novartis
- Treatment: Phenazoline · Novartis
- Treatment: Thenylene
- Treatment: Azatidine
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing